Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1994
Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity
E V Van Cauter, K S Polonsky, J D Blackman, et al.
Biochemical and Biophysical Research Communications
|
November 21, 1996
Ultradian oscillations of leptin secretion in humans
M K Sinha, J Sturis, J Ohannesian, et al.
Diabetologia
|
November 7, 1999
Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations
B Nyholm, M Walker, C H Gravholt, et al.
Diabetes
|
August 3, 2000
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes
M Hollingdal, C B Juhl, S M Pincus, et al.
Diabetes
|
May 1, 1994
Compensation in pancreatic beta-cell function in subjects with glucokinase mutations
J Sturis, I J Kurland, M M Byrne, et al.
Diabetes
|
December 1, 1995
Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat
Y Tokuyama, J Sturis, A M DePaoli, et al.
Journal of Biological Rhythms
|
January 1, 1993
Preliminary studies on the immediate phase-shifting effects of light and exercise on the human circadian clock
E Van Cauter, J Sturis, M M Byrne, et al.
Diabetes, Obesity & Metabolism
|
March 13, 2008
Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats
P J Larsen, E M Wulff, C F Gotfredsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2005
Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetes
M Hollingdal, J Sturis, M-A Gall, et al.
Diabetes, Obesity & Metabolism
|
June 13, 2009
Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats
C L Brand, E D Galsgaard, D Tornehave, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1994
Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity
E V Van Cauter, K S Polonsky, J D Blackman, et al.
Biochemical and Biophysical Research Communications
|
November 21, 1996
Ultradian oscillations of leptin secretion in humans
M K Sinha, J Sturis, J Ohannesian, et al.
Diabetologia
|
November 7, 1999
Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations
B Nyholm, M Walker, C H Gravholt, et al.
Diabetes
|
August 3, 2000
Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes
M Hollingdal, C B Juhl, S M Pincus, et al.
Diabetes
|
May 1, 1994
Compensation in pancreatic beta-cell function in subjects with glucokinase mutations
J Sturis, I J Kurland, M M Byrne, et al.
Diabetes
|
December 1, 1995
Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat
Y Tokuyama, J Sturis, A M DePaoli, et al.
Journal of Biological Rhythms
|
January 1, 1993
Preliminary studies on the immediate phase-shifting effects of light and exercise on the human circadian clock
E Van Cauter, J Sturis, M M Byrne, et al.
Diabetes, Obesity & Metabolism
|
March 13, 2008
Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats
P J Larsen, E M Wulff, C F Gotfredsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 24, 2005
Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetes
M Hollingdal, J Sturis, M-A Gall, et al.
Diabetes, Obesity & Metabolism
|
June 13, 2009
Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats
C L Brand, E D Galsgaard, D Tornehave, et al.
Page
of 6